Beactica Announces Drug Discovery Agreement With Cubist Pharmaceuticals
UPPSALA, Sweden, May 26 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (…